心脏瓣膜介入治疗新器械专题会VII
Symposium on Novel Devices for Cardiac Valve Interventional Therapy VII
04/19 08:00-10:00
开元厅B (Room Kaiyuan B)
-
08:00-10:00
-
08:00-10:00
-
08:00-08:05
-
08:05-08:10新捷构 通未来-全新混合式自膨主动脉瓣膜Acurate Neo2™启动仪式"Precision today, access tomorrow" - Launch Ceremony of the New Hybrid Self-Expanding Aortic Valve Acurate Neo2™
-
08:10-08:30全新混合式自膨介入主动脉瓣膜特点及欧洲患者选择经验分享Experience Sharing on the Characteristics of the New Hybrid Self-Expanding Transcatheter Aortic Valve and the Patient Selection in Europe
-
08:30-08:50全新混合式自膨介入主动脉瓣膜临床试验数据解读及设计特点Clinical Trial Data Interpretation and Design Features of the New Hybrid Self-Expanding Transcatheter Aortic Valve
-
08:50-09:05在前行中思考-安全TAVR理念的践行Thinking While Moving Forward - The Practice of Safe TAVR Philosophy
-
09:05-09:25交界对齐-开放式框架自膨短瓣设计和应用优势Commissural Alignment – Design and Clinical Advantages of Open-Frame Short Self-Expanding Valves
-
09:25-09:40全新体验-重度钙化、横位心TAVR患者一例A Novel Approach-Transcatheter Aortic Valve Replacement in a Patient with Severe Calcification and Horizontal Aortic Root
-
09:40-09:55极限挑战-低冠脉开口应用TAVR病例一例Extreme Challenge - A Case of the Application in Patients with Low Coronary Artery Ostia
-
09:55-10:00讨论： 全新混合式自膨介入主动脉瓣膜应用的首选人群是哪些？Discussion: Who are the Preferred Patient Populations for the Application of the New Hybrid Self-Expanding Transcatheter Aortic Valve?